Lixte Biotechnology Holdings Inc banner

Lixte Biotechnology Holdings Inc
NASDAQ:LIXT

Watchlist Manager
Lixte Biotechnology Holdings Inc Logo
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
Watchlist
Price: 2.93 USD -3.93%
Market Cap: $18.4m

During the last 3 months Lixte Biotechnology Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 18% over this period (open performance analysis).

The last transaction was made on Oct 3, 2023 by Bernards Rene , who bought 13.9k USD worth of LIXT shares.

Last Transactions:
Van Der Baan Bastiaan Jeroen
$+28k
Bernards Rene
$+13.9k
Bernards Rene
$+13.9k
Bernards Rene
$+10.2k
Bernards Rene
$+10.2k
Van Der Baan Bastiaan Jeroen
$+490
Van Der Baan Bastiaan Jeroen
$+4.9k
Bernards Rene
$+765
Bernards Rene
$+610
Forman Eric
$+600
Forman Eric
$+138.9
Forman Eric
$+81.8
Brown Regina
$+136.8
Forman Eric
$+433.8
Forman Eric
$+261.8
Bernards Rene
$+2.8k
Ho Hung Tak
$+20k
Palmedo Philip F
$+10k
Greenberg Family Trust
$+25k
Kovach John S
$+10k
Forman Stephen J.
$+10k
Yen Yun
$+25k
Schwartzberg Gil
$+50k
Schwartzberg Gil
$+8.7k
Palmedo Philip F
$+833.5
Forman Stephen J.
$+833.5
Riggs Arthur
$+10.5k
Schwartzberg Gil
$+988.8
Forman Eric
$+50.1
Forman Eric
$+216
Forman Eric
$+10.5
Riggs Jane Merrill
$+29.2k
View All Transactions

During the last 3 months Lixte Biotechnology Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 18% over this period (open performance analysis).

The last transaction was made on Oct 3, 2023 by Bernards Rene , who bought 13.9k USD worth of LIXT shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Lixte Biotechnology Holdings Inc
Insider Trading Chart

Lixte Biotechnology Holdings Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Lixte Biotechnology Holdings Inc
Last Insider Transactions

Global
Insiders Monitor

Lixte Biotechnology Holdings Inc
Glance View

Market Cap
18.4m USD
Industry
Biotechnology

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. The company is headquartered in East Setauket, New York and currently employs 3 full-time employees. The company went IPO on 2007-09-21. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and encompasses two categories of compounds at various stages of pre-clinical and clinical development that has the therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. The firm has developed two series of pharmacologically active drugs, the LB-100 series and the LB-200 series. The LB-100 series consists of structures, which is treated not only several types of cancer but also vascular and metabolic diseases. The LB-200 series contains compounds, which are useful for the treatment of chronic hereditary diseases.

LIXT Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett